Acura Pharmaceuticals Inc (ACUR.O)
ACUR.O on Consolidated Issue listed on NASDAQ Capital Market
2.30USD
21 May 2013
2.30USD
21 May 2013
Price Change (% chg)
$-0.10 (-4.17%)
$-0.10 (-4.17%)
Prev Close
$2.40
$2.40
Open
$2.43
$2.43
Day's High
$2.43
$2.43
Day's Low
$2.24
$2.24
Volume
319,569
319,569
Avg. Vol
730,547
730,547
52-wk High
$4.50
$4.50
52-wk Low
$1.06
$1.06
About
Acura Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies. Aversion is a mixture of inactive ingredients incorporated into pharmaceutical tablets and... (more)
Overall
| Beta: | 0.82 |
| Market Cap (Mil.): | $111.30 |
| Shares Outstanding (Mil.): | 46.38 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ACUR.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 54.65 | 35.85 |
| EPS (TTM): | -0.24 | -- | -- |
| ROI: | -40.70 | 0.83 | 18.76 |
| ROE: | -40.70 | 1.79 | 19.57 |
Honda to recall 871,000 vehicles for roll-away problem
- Honda Motor Co will recall 871,000 vehicles that could roll away after the ignition key has been removed, including 807,000 in the United States, the company said on Wednesday.
Honda says it is reviewing its U.S. marketing
- Honda Motor Co's U.S. arm has started a review of its advertising accounts for its Honda and Acura brands, American Honda Motor Co said on Thursday.
Honda says it is reviewing its U.S. marketing
Dec 6 - Honda Motor Co's U.S. arm has started a review of its advertising accounts for its Honda and Acura brands, American Honda Motor Co said on Thursday.
Competitors
| Price | Change | |
|---|---|---|
| Pain Therapeutics, Inc. (PTIE.OQ) | $3.01 | +0.12 |
| Pfizer Inc. (PFE.N) | $28.49 | -0.21 |
| Grifols SA (GRLS.MC) | €28.68 | -0.12 |
| Grifols SA (GRLSbn.MC) | €20.86 | -0.14 |
| Onyx Pharmaceuticals, Inc. (ONXX.OQ) | $93.43 | -0.91 |
| AstraZeneca plc (AZN.L) | 3,394.50p | +4.00 |
| Bayer AG (BAYGn.DE) | €84.65 | +0.53 |
| Bayer AG (BAYE.F) | -- | -- |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

